The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): a multicentre case-control study

《The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): a multicentre case-control study》

打印

作者: Marta Di Forti;Diego Quattrone;Tom P Freeman;Giada Tripoli;Charlotte Gayer-Anderson;Harriet Quigley;Victoria Rodriguez;Hannah E Jongsma;Laura Ferraro;Caterina La Cascia;Daniele La Barbera;Ilaria Tarricone;Domenico Berardi;Andrei Szöke;Celso Arango;Andrea

来源: HABITAT INTERNATIONAL,Vol.6,P.427-436

语言: 英文

关键字

作者单位: Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, King's College London, London, UK;Department of Addiction, Institute of Psychiatry, King's College London, London, UK;Institute of Psychiatry, Psychology and Neuroscience and Department of Psychosis Studies, Institute of Psychiatry, King's College London, London, UK;Department of Health Service and Population Research, Institute of Psychiatry, King's College London, London, UK;National Institute for Health Research (NIHR) Mental Health Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London, UK;South London and Maudsley NHS Mental Health Foundation Trust, London, UK;Addiction and Mental Health Group (AIM), Department of Psychology, University of Bath, Bath, UK;Department of Psychiatry, University of Cambridge, Cambridge, UK;Department of Experimental Biomedicine and Clinical Neuroscience, University of Palermo, Palermo, Italy;Department of Medical and Surgical Science, Psychiatry Unit, Alma Mater Studiorum Università di Bologna, Bologna, Italy;INSERM U955, Equipe 15, Institut National de la Santé et de la Recherche Médicale, Créteil, Paris, France;Department of Child and Adolescent Psychiatry, Hospital General Universitario Gregorio Marañón, School of Medicine, Universidad Complutense, IiSGM (CIBERSAM), Madrid, Spain;Etablissement Public de Santé Maison Blanche, Paris, France;Department of Psychiatry, Early Psychosis Section, Academic Medical Centre, University of Amsterdam, Amsterdam, Netherlands;Barcelona Clinic Schizophrenia Unit, Neuroscience Institute, Hospital clinic, Department of Medicine, University of Barcelona, IDIBAPS, CIBERSAM, Barcelona, Spain;Division of Psychiatry, Department of Neuroscience and Behaviour, Ribeirão Preto Medical School, University of São Paulo, São Paulo, Brazil;Department of Preventative Medicine, Faculdade de Medicina FMUSP, University of São Paulo, São Paulo, Brazil;Rivierduinen Institute for Mental Health Care, Leiden, Netherlands;CAMEO Early Intervention Service, Cambridgeshire & Peterborough NHS Foundation Trust, Cambridge, UK;Psylife Group, Division of Psychiatry, University College London, London, UK;Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, South Limburg Mental Health Research and Teaching Network, Maastricht University Medical Centre, Maastricht, Netherlands;Centre for Genomic Sciences, Li KaShing Faculty of Medicine, The University of Hong Kong, Hong Kong, China;Brain Centre Rudolf Magnus, Utrecht University Medical Centre, Utrecht, The Netherlands;Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, King's College London, London, UK;Department of Addiction, Institute of Psychiatry, King's College London, London, UK;Institute of Psychiatry, Psychology and Neuroscience and Department of Psychosis Studies, Institute of Psychiatry, King's College London, London, UK;Department of Health Service and Population Research, Institute of Psychiatry, King's College London, London, UK;National Institute for Health Research (NIHR) Mental Health Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London, UK;South London and Maudsley NHS Mental Health Foundation Trust, London, UK;Addiction and Mental Health Group (AIM), Department of Psychology, University of Bath, Bath, UK;Department of Psychiatry, University of Cambridge, Cambridge, UK;Department of Experimental Biomedicine and Clinical Neuroscience, University of Palermo, Palermo, Italy;Department of Medical and Surgical Science, Psychiatry Unit, Alma Mater Studiorum Università di Bologna, Bologna, Italy;INSERM U955, Equipe 15, Institut National de la Santé et de la Recherche Médicale, Créteil, Paris, France;Department of Child and Adolescent Psychiatry, Hospital General Universitario Gregorio Marañón, School of Medicine, Universidad Complutense, IiSGM (CIBERSAM), Madrid, Spain;Etablissement Public de Santé Maison Blanche, Paris, France;Department of Psychiatry, Early Psychosis Section, Academic Medical Centre, University of Amsterdam, Amsterdam, Netherlands;Barcelona Clinic Schizophrenia Unit, Neuroscience Institute, Hospital clinic, Department of Medicine, University of Barcelona, IDIBAPS, CIBERSAM, Barcelona, Spain;Division of Psychiatry, Department of Neuroscience and Behaviour, Ribeirão Preto Medical School, University of São Paulo, São Paulo, Brazil;Department of Preventative Medicine, Faculdade de Medicina FMUSP, University of São Paulo, São Paulo, Brazil;Rivierduinen Institute for Mental Health Care, Leiden, Netherlands;CAMEO Early Intervention Service, Cambridgeshire & Peterborough NHS Foundation Trust, Cambridge, UK;Psylife Group, Division of Psychiatry, University College London, London, UK;Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, South Limburg Mental Health Research and Teaching Network, Maastricht University Medical Centre, Maastricht, Netherlands;Centre for Genomic Sciences, Li KaShing Faculty of Medicine, The University of Hong Kong, Hong Kong, China;Brain Centre Rudolf Magnus, Utrecht University Medical Centre, Utrecht, The Netherlands;Articles"}]},{"#name":"title","$":{"xmlns:ce":true,"id":"cetitle10

摘要